NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001911

Registered date:01/05/2009

Beneficial effect of Raloxifene on high turn-over bone in chronic hemodialysis patients

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedchronic kidney disease postmenopausal osteoporosis
Date of first enrollment2009/05/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)medication of Raloxifene

Outcome(s)

Primary Outcomeserum bone alkaline phosphatase (BAP) level serum bone-specific tartrate-resistant acid phosphatase (TRAP5b) level
Secondary Outcomeserum levels od iPTH, calcium, phosphate, total cholesterol, and triacylglyceride

Key inclusion & exclusion criteria

Age minimum50years-old
Age maximumNot applicable
GenderFemale
Include criteria
Exclude criteria1. Patients prescribed with bisphosphonate, aluminium, lanthanum, cinacalcet. 2. Patients with venous thrombosis or its history. 3. Immobilised patients in long term. 4. Patients with anti-phospholipid antibody syndrome. 5. Patients in pregnancy (including its possibility) and lactation. 6. Patinets with history of allergy to Raloxifene. 7. Patients with liver dysfunction.

Related Information

Contact

public contact
Name Katsuyuki Nagatoya
Address 2-7 Takatsuki, Osaka Japan
Telephone 072-683-1221
E-mail katsuyuki@poh.osaka-med.ac.jp
Affiliation Osaka Medical College Blood Purification Center
scientific contact
Name Toru Inoue
Address 2-7 Takatsuki, Osaka Japan
Telephone 072-683-1221
E-mail
Affiliation Osaka College of Medicine Blood Purification Center